Bibliographic Details
| Title: |
Safety of an extension of use of oil from Schizochytrium limacinum (strain FCC‐3204) as a novel food pursuant to Regulation (EU) 2015/2283. |
| Authors: |
Turck, Dominique, Bohn, Torsten, Cámara, Montaña, Castenmiller, Jacqueline, De Henauw, Stefaan, Hirsch‐Ernst, Karen Ildico, Jos, Ángeles, Maciuk, Alexandre, Mangelsdorf, Inge, McNulty, Breige, McArdle, Harry J., Naska, Androniki, Pentieva, Kristina, Siani, Alfonso, Thies, Frank, Aguilera‐Gómez, Margarita, Cubadda, Francesco, Frenzel, Thomas, Heinonen, Marina, Neuhäuser‐Berthold, Monika |
| Source: |
EFSA Journal; Oct2024, Vol. 22 Issue 10, p1-16, 16p |
| Subject Terms: |
DOCOSAHEXAENOIC acid, DIETARY supplements, MANUFACTURING processes, FOOD safety, ALLERGENS |
| Abstract: |
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of an extension of use of oil from Schizochytrium limacinum (strain FCC‐3204) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The extension of use pertains to the use of the NF as a food ingredient in protein products at a maximum use level of 1 g of docosahexaenoic acid (DHA) in 100 g of product. The Panel considers that the information provided on the composition and the production process is sufficiently described and does not raise safety concerns. S. limacinum was attributed the qualified presumption of safety (QPS) status with the qualification 'for production purposes only'. Data provided demonstrated the absence of viable cells in the NF. Under the proposed extension of use, the highest intake estimate (at the 95th percentile) of DHA from the NF in protein products is 6.3 mg DHA/kg bw per day for adolescents. The Panel notes that the exposure to DHA from the new intended use of the NF in protein products is very low compared to the exposure to DHA from the already authorised food categories (excluding food supplements). The Panel concludes that the NF (oil from S. limacinum (FCC‐3204)) is safe under the new intended use. [ABSTRACT FROM AUTHOR] |
|
Copyright of EFSA Journal is the property of European Food Safety Authority and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
